Targeting chaperon protein HSP70 as a novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia

• Chen Hu,
• Fengming Zou,
• Aoli Wang,
• Weili Miao,
• Qianmao Liang,
• Ellen L. Weisberg,
• Yinsheng Wang,
• Jing Liu,
• Wenchao Wang,
• Qingsong Liu

Affiliations

Chen Hu

Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences

Fengming Zou

Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences

Aoli Wang

Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences

Weili Miao

Department of Chemistry, University of California-Riverside

Qianmao Liang

Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences

Ellen L. Weisberg

Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School

Yinsheng Wang

Department of Chemistry, University of California-Riverside

Jing Liu

Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences

Wenchao Wang

Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences

Qingsong Liu

Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences